Gennex Laboratories Ltd

Gennex Laboratories Ltd (GENNEX) is a micro-cap Healthcare company valued at ₹204 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Gennex Laboratories Ltd last traded at ₹9.1, modestly up 0.89% on the day.

Recent developments

2026-06-30: The company reported a net profit of ₹5 crore for the latest quarter, which fell 7.0% compared to the same quarter a year earlier. 2026-06-30: Promoter shares pledged reached 21.77% of promoter holding, indicating potential liquidity concerns.

Financial performance

The company's business is growing, with annual revenue rising 25.3% and annual net profit increasing 15.8%. However, the net profit margin narrowed 1.0 percentage points to 12.1%, while return on equity remained at 8.3%.

Valuation multiples

The stock trades at 12.0 times earnings, a discount to the Healthcare median of 32.0, 1.22 times book value.

Things to watch

The stock is 44.3% below its 52-week high, reflecting a significant decline from recent peak levels. The net profit margin has narrowed by 1.0 percentage points, which could signal pressure on profitability.

Where it stands

Gennex Laboratories Ltd has shown strong revenue growth over the past three and five years, but the latest quarter's net profit declined compared to the same period a year earlier. The stock's price is significantly lower than its 52-week high, and promoter shares pledged suggest potential liquidity risks.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.